Beer review

Noted Harvard epidemiologist linkurl:Meir Stampfer;http://www.hsph.harvard.edu/facres/stmpfr.html has decided that he no longer wants to publicly tout the benefits of beer anymore at benefits sponsored by? surprise, Anheuser-Busch, brewer of approximately 30 beers in the U.S. alone. The researcher?s decision to affiliate himself with the company sparked outrage among some addiction experts, who accused Stampfer of unethical practice. Stampfer defended himself by arguing that he was simply prom

Written byAlison McCook
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Noted Harvard epidemiologist linkurl:Meir Stampfer;http://www.hsph.harvard.edu/facres/stmpfr.html has decided that he no longer wants to publicly tout the benefits of beer anymore at benefits sponsored by? surprise, Anheuser-Busch, brewer of approximately 30 beers in the U.S. alone. The researcher?s decision to affiliate himself with the company sparked outrage among some addiction experts, who accused Stampfer of unethical practice. Stampfer defended himself by arguing that he was simply promoting the benefits of beer, which often gets overlooked by studies that say moderate amounts of alcohol can be healthy, but focus on wine, not other types of alcohol. Stampfer and others linkurl:have found;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15979440&query_hl=5&itool=pubmed_docsum that people can benefit from beer and liquor, as well. Stampfer also said that he never accepted money from Anheuser-Busch for his lectures about beer?s benefits. According to the Web site linkurl:Join Together;http://www.jointogether.org/home/, which helps fight substance abuse, Stampfer has not been paid directly, but the company gave $150,000 to Harvard as scholarship money. "I was not compensated, and there was no company input to my talks," Stampfer said. "There was nothing unethical here." However, when the Wall Street Journal reported last month about Stampfer?s activities, some addiction experts voiced concerns. "What is stunning and appalling in this episode is the apparent abandonment of ethics and professional pride on the part of Dr. Stampfer and the Harvard School of Public Health," said Steve Meisburg, a Join Together National Policy Panel member on Substance Abuse Prevention. Sure, having a relationship ? albeit, an indirect one ? with Anheuser-Busch makes Stampfer?s actions appear? well, somewhat sudsy. But who else is going to sponsor talks about the benefits of beer? And if Stampfer?s statements are supported by peer-reviewed research, what?s the harm? I think many of us would be happy to discuss it over a couple of heart-healthy beers. Un-sponsored, of course.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies